Tag: Drug Promotion

Drugs have not been tested in Russia may get access to the Russian market

This applies to drugs from the European Union, the United States and Japan. As explained the Ministry of Industry and Trade, the issue can be resolved at the level of intergovernmental agreements.

Prestige BioPharma and Alvogen will launch Trastuzumab biosimilar in Europe

Prestige BioPharma and Alvogen announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Trastuzumab biosimilar in Central and Eastern Europe.

Lupin and Mylan will commercialize Etanercept

Pharma major Lupin Limited and global pharmaceutical company Mylan N.V. announced that the two companies will partner to commercialize a biosimilar to Enbrel® (Etanercept).

Advertising of medicines may disappear from TV programs in Russia

A draft law on banning the advertising of medicines on TV was submitted to Russian State Duma. According to State Duma, the motives of advertisers are usually far removed from genuine concern about the patient health.

Takeda buys a range of OTC medicines from Unipharm

Takeda Pharmaceutical Company Limited announced the signing of a framework agreement to acquire a range of over-the-counter medicines and food supplements from Unipharm Inc.

Russian deputies propose to ban advertising of medicines on television and radio

A group of deputies of the Russian State Duma led by Vladimir Zhirinovsky proposed to introduce a rule preventing the advertising of medicinal products in television and radio programs